| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |